JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB325681

Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46]

  • RabMAb
  • Recombinant
  • 20ul selling size
  • KO Validated
  • What is this?

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal SQSTM1 / p62 antibody. Suitable for I-ELISA, ICC/IF, WB and reacts with Synthetic peptide - Human, Human samples.

View Alternative Names

ORCA, OSIL, SQSTM1, Sequestosome-1, EBI3-associated protein of 60 kDa, Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa, Ubiquitin-binding protein p62, EBIAP, p60, p62

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)

Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized HeLa(human cervical adenocarcinoma epithelial cell) untreated, HeLa treated with TNF alpha (100 ng/ml) and IKK-16(1uM) for 4 hours and HeLa treated with TNF alpha (100 ng/ml), IKK-16(1uM) and Z-VAD-FM(20uM) for 4 hours cells labelling SQSTM1 / p62 with ab325681 at 1/50 (10.24 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green).

Confocal image showing increased cytoplasmic staining in HeLa cells treated with TNF alpha (100 ng/ml) and IKK-16 (1uM) for 4 hours (panel B). No staining was observed in untreated HeLa cells (panel A), or HeLa cells treated with TNF alpha (100 ng/ml), IKK-16 (1uM) and Z-VAD-FM (20uM) for 4 hours (panel C). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

ab7291 Anti-alpha Tubulin mouse monoclonal antibody was used to counterstain tubulin at 1/1000 dilution, followed by ab150120 Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) at 1/1000 dilution (Magenta).

Immunocytochemistry/ Immunofluorescence - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)

Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized wildtype HAP1 (human chronic myelogenous leukemia near-haploid cell) untreated, wildtype HAP1 treated with TNF alpha (100 ng/ml) and IKK-16 (1µM) for 4 hours, SQSTM1 knockout HAP1 untreated and SQSTM1 knockout HAP1 treated with TNF alpha (100 ng/ml) and IKK-16 (1µM) for 4 hours labelling SQSTM1 / p62 with ab325681 at 1/50 (10.24 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green).

Confocal image showing increased cytoplasmic staining in wildtype HAP1 cells treated with TNF alpha (100 ng/ml) and IKK-16 (1uM) for 4 hours (panel B). No staining was observed in untreated wildtype HAP1 cells (panel A), untreated SQSTM1 knockout HAP1 cells (panel C), or SQSTM1 knockout HAP1 cells treated with TNF alpha (100 ng/ml) and IKK-16 (1uM) for 4 hours (panel D). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

ab7291 Anti-alpha Tubulin mouse monoclonal antibody was used to counterstain tubulin at 1/1000 dilution, followed by ab150120 Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) at a 1/1000 dilution (Magenta).

Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
  • WB

Lab

Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

Total protein Anti-SQSTM1 antibody [EPR18351] (ab207305) (1 : 1000).

All lanes:

Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (ab325681) at 1/1000 dilution

Lane 1:

Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

HeLa treated with 10ng/ml TNF alpha and 1uM IKK-16 for 4 hours whole cell lysate at 20 µg

Lane 3:

HeLa treated with 10ng/ml TNF alpha, 1uM IKK-16 and 20uM Z-VAD-FMK for 4 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 40 kDa,36 kDa

false

Exposure time: 10s

Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
  • WB

Lab

Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

In Western blot, ab325681 was shown to bind specifically to SQSTM1. Target of interest was observed at 40 kDa in TNF alpha and IKK-16 treated wild-type HAP1 cell lysates (lane 2) with no signal observed at this size in the SQSTM1 knockout cell line (lanes 3-4, knockout cell line ab240635).

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).

Total protein Anti-SQSTM1 antibody [EPR18351] (ab207305) (1 : 1000).

All lanes:

Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (ab325681) at 1/1000 dilution

Lane 1:

Untreated parental HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 60 µg

Lane 2:

HAP1 treated with 10ng/ml TNF alpha and 1uM IKK-16 for 4 hours whole cell lysate at 60 µg

Lane 3:

Untreated SQSTM1 knockout HAP1 whole cell lysate at 60 µg

Lane 4:

SQSTM1 knockout HAP1 treated with 10ng/ml TNF alpha and 1uM IKK-16 for 4 hours whole cell lysate at 60 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 40 kDa,36 kDa

false

Exposure time: 180s

Indirect ELISA - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
  • I-ELISA

Lab

Indirect ELISA - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)

Indirect ELISA analysis of ab325681 at 1000-0 ng/ml. The Secondary antibody used was Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1 : 2500 dilution dilution.

Antigen : cleaved human SQSTM1 at D329 (N-terminal);Full length human SQSTM1.

Antigen concentration : 1000 ng/ml

This antibody does not cross-react with full length human SQSTM1.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR29289-46

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, I-ELISA

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody does not cross-react with full length human SQSTM1 by ELISA.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IELISA" : {"fullname" : "Indirect ELISA", "shortname":"I-ELISA"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IELISA-species-checked": "guaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Synthetic peptide - Human": { "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "31.25 ng/mL", "IELISA-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Molecular adapter required for selective macroautophagy (aggrephagy) by acting as a bridge between polyubiquitinated proteins and autophagosomes (PubMed : 15340068, PubMed : 15953362, PubMed : 16286508, PubMed : 17580304, PubMed : 20168092, PubMed : 22017874, PubMed : 22622177, PubMed : 24128730, PubMed : 28404643, PubMed : 29343546, PubMed : 29507397, PubMed : 31857589, PubMed : 33509017, PubMed : 34471133, PubMed : 34893540, PubMed : 35831301, PubMed : 37306101, PubMed : 37802024). Promotes the recruitment of ubiquitinated cargo proteins to autophagosomes via multiple domains that bridge proteins and organelles in different steps (PubMed : 16286508, PubMed : 20168092, PubMed : 22622177, PubMed : 24128730, PubMed : 28404643, PubMed : 29343546, PubMed : 29507397, PubMed : 34893540, PubMed : 37802024). SQSTM1 first mediates the assembly and removal of ubiquitinated proteins by undergoing liquid-liquid phase separation upon binding to ubiquitinated proteins via its UBA domain, leading to the formation of insoluble cytoplasmic inclusions, known as p62 bodies (PubMed : 15911346, PubMed : 20168092, PubMed : 22017874, PubMed : 24128730, PubMed : 29343546, PubMed : 29507397, PubMed : 31857589, PubMed : 37802024). SQSTM1 then interacts with ATG8 family proteins on autophagosomes via its LIR motif, leading to p62 body recruitment to autophagosomes, followed by autophagic clearance of ubiquitinated proteins (PubMed : 16286508, PubMed : 17580304, PubMed : 20168092, PubMed : 22622177, PubMed : 24128730, PubMed : 28404643, PubMed : 37802024). SQSTM1 is itself degraded along with its ubiquitinated cargos (PubMed : 16286508, PubMed : 17580304, PubMed : 37802024). Also required to recruit ubiquitinated proteins to PML bodies in the nucleus (PubMed : 20168092). Also involved in autophagy of peroxisomes (pexophagy) in response to reactive oxygen species (ROS) by acting as a bridge between ubiquitinated PEX5 receptor and autophagosomes (PubMed : 26344566). Acts as an activator of the NFE2L2/NRF2 pathway via interaction with KEAP1 : interaction inactivates the BCR(KEAP1) complex by sequestering the complex in inclusion bodies, promoting nuclear accumulation of NFE2L2/NRF2 and subsequent expression of cytoprotective genes (PubMed : 20452972, PubMed : 28380357, PubMed : 33393215, PubMed : 37306101). Promotes relocalization of 'Lys-63'-linked ubiquitinated STING1 to autophagosomes (PubMed : 29496741). Involved in endosome organization by retaining vesicles in the perinuclear cloud : following ubiquitination by RNF26, attracts specific vesicle-associated adapters, forming a molecular bridge that restrains cognate vesicles in the perinuclear region and organizes the endosomal pathway for efficient cargo transport (PubMed : 27368102, PubMed : 33472082). Sequesters tensin TNS2 into cytoplasmic puncta, promoting TNS2 ubiquitination and proteasomal degradation (PubMed : 25101860). May regulate the activation of NFKB1 by TNF, nerve growth factor (NGF) and interleukin-1 (PubMed : 10356400, PubMed : 10747026, PubMed : 11244088, PubMed : 12471037, PubMed : 16079148, PubMed : 19931284). May play a role in titin/TTN downstream signaling in muscle cells (PubMed : 15802564). Adapter that mediates the interaction between TRAF6 and CYLD (By similarity).
See full target information SQSTM1

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com